I agree that this site is using cookies. You can find further informations here.
X
Ottensmeier, C.
159  results:
Search for persons X
?
1

Emerging role of clinical trials assistants (CTAs) – integr..:

Fixmer, C. ; Lane, M. ; Johnson, B....
Lung Cancer.  115 (2018)  - p. S14-S15 , 2018
Link: https://doi.org/10.1016/..
 
?
2

CONFIRM: a phase III randomised trial to evaluate the effic..:

Hanna, G. ; Griffiths, G. ; Kirkpatrick, E.V....
Lung Cancer.  115 (2018)  - p. S84 , 2018
Link: https://doi.org/10.1016/..
 
?
3

Real-world use of anti-PD-1 checkpoint inhibitors in the ma..:

Remer, M. ; Muller, D. ; Cave, J....
Lung Cancer.  115 (2018)  - p. S35 , 2018
Link: https://doi.org/10.1016/..
 
?
4

Uveal Melanoma UK National Guidelines:

Nathan, P. ; Cohen, V. ; Coupland, S....
European Journal of Cancer.  51 (2015)  16 - p. 2404-2412 , 2015
Link: https://doi.org/10.1016/..
 
?
5

Erratum: Systematic review and meta-analysis of immunohisto..:

Matthews, LH McCormick ; Noble, F ; Tod, J...
British Journal of Cancer.  113 (2015)  12 - p. 1746-1746 , 2015
Link: https://doi.org/10.1038/..
 
?
6

Systematic review and meta-analysis of immunohistochemical ..:

McCormick Matthews, L H ; Noble, F ; Tod, J...
British Journal of Cancer.  113 (2015)  1 - p. 107-118 , 2015
Link: https://doi.org/10.1038/..
 
?
7

3353 Seropositivity to tumour antigens as a potential new b..:

Clark, L. ; Hepburne-Scott, H. ; Ottensmeier, C....
European Journal of Cancer.  51 (2015)  - p. S686 , 2015
Link: https://doi.org/10.1016/..
 
?
8

TIME, a Phase 2b/3 Study Evaluating TG4010 in Combination W..:

Quoix, E. ; Losonczy, G. ; Forget, F....
International Journal of Radiation Oncology*Biology*Physics.  90 (2014)  5 - p. S35 , 2014
Link: https://doi.org/10.1016/..
 
?
9

Afatinib use in non-small cell lung cancer previously sensi..:

Khan, F. ; Ottensmeier, C. ; Popat, S....
European Journal of Cancer.  50 (2014)  10 - p. 1717-1721 , 2014
Link: https://doi.org/10.1016/..
 
?
10

26 Treatment and outcome in epidermal growth factor recepto..:

Killick, E. ; Bennett, J. ; Bates, A....
Lung Cancer.  83 (2014)  - p. S10-S11 , 2014
Link: https://doi.org/10.1016/..
 
?
11

106. Initial UK experience of melphalan percutaneous hepati..:

Stedman, B. ; Wilson, I. ; El Berm, H....
European Journal of Surgical Oncology (EJSO).  40 (2014)  11 - p. S50 , 2014
Link: https://doi.org/10.1016/..
 
?
12

30 Afatanib use in non-small cell cancer patients whose tum..:

Khan, F. ; Ottensmeier, C. ; Popat, S..
Lung Cancer.  79 (2013)  - p. S10-S11 , 2013
Link: https://doi.org/10.1016/..
 
?
13

T Cell Assays and MIATA: The Essential Minimum for Maximum ..:

Britten, C.M. ; Janetzki, S. ; Butterfield, L.H....
Immunity.  37 (2012)  1 - p. 1-2 , 2012
Link: https://doi.org/10.1016/..
 
?
14

Response definition criteria for ELISPOT assays revisited:

Moodie, Z. ; Price, L. ; Gouttefangeas, C....
Cancer Immunology, Immunotherapy.  59 (2010)  10 - p. 1489-1501 , 2010
Link: https://doi.org/10.1007/..
 
?
15

Serum is not required for ex vivo IFN-γ ELISPOT: a collabor..:

Mander, A. ; Gouttefangeas, C. ; Ottensmeier, C....
Cancer Immunology, Immunotherapy.  59 (2010)  4 - p. 619-627 , 2010
Link: https://doi.org/10.1007/..
 
1-15